Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis
The duration of immunotherapy > 12 months is associated with better OS in patients with first-line R/M NPC.
Authors
- Ming‐Yuan Chen (ORCID: https://orcid.org/0000-0003-4793-0902)
- Xiwei Xu (ORCID: https://orcid.org/0000-0002-2357-271X)
- Qiaodan Liu (ORCID: https://orcid.org/0000-0001-8696-3833)
- Yingpeng Peng
- Xi Chu (ORCID: https://orcid.org/0000-0001-8603-0267)
- Siyang Wang (ORCID: https://orcid.org/0009-0004-8733-3103)
- Dasong Zha
- Linghan Meng (ORCID: https://orcid.org/0009-0001-5955-840X)
- Tianze Liu (ORCID: https://orcid.org/0000-0002-1754-929X)
- Jijin Yao
Institutions
- Sun Yat-sen University (CN)
- Guangdong Academy of Sciences (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- State Key Laboratory of Oncology in South China
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1007/s00262-025-04250-6
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- Guangdong Medical Research Foundation
- National Science and Technology Major Project
- Sun Yat-sen University Cancer Center